Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 1
2009 1
2013 1
2014 2
2015 6
2016 2
2018 7
2019 6
2020 11
2021 7
2022 8
2023 8
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Treatment options for progression or recurrence of glioblastoma: a network meta-analysis.
McBain C, Lawrie TA, Rogozińska E, Kernohan A, Robinson T, Jefferies S. McBain C, et al. Cochrane Database Syst Rev. 2021 May 4;5(1):CD013579. doi: 10.1002/14651858.CD013579.pub2. Cochrane Database Syst Rev. 2021. PMID: 34559423 Free PMC article. Review.
Regorafenib (REG): REG may improve OS compared with LOM (HR 0.50, 95% CI 0.33 to 0.76; low-certainty evidence). Evidence on PFS was very low certainty and more evidence on REG is needed. Temozolomide (TMZ) plus Depatux-M (ABT414): For OS, low-certainty eviden …
Regorafenib (REG): REG may improve OS compared with LOM (HR 0.50, 95% CI 0.33 to 0.76; low-certainty evidence). Evidence on PFS was v …
Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis.
Brown TJ, Brennan MC, Li M, Church EW, Brandmeir NJ, Rakszawski KL, Patel AS, Rizk EB, Suki D, Sawaya R, Glantz M. Brown TJ, et al. JAMA Oncol. 2016 Nov 1;2(11):1460-1469. doi: 10.1001/jamaoncol.2016.1373. JAMA Oncol. 2016. PMID: 27310651 Free PMC article. Review.
Data were analyzed to assess mortality after gross total resection (GTR), subtotal resection (STR), and biopsy. The body of evidence was evaluated according to Grading of Recommendations Assessment, Development, and Evaluation (GRADE) criteria and PRISMA guidelines. …
Data were analyzed to assess mortality after gross total resection (GTR), subtotal resection (STR), and biopsy. The body of evidence was eva …
Psychiatric symptoms in children with low-grade glioma and craniopharyngioma: A systematic review.
Sherman SJ, Tanaka R, Qaddoumi I. Sherman SJ, et al. J Psychiatr Res. 2022 Apr;148:240-249. doi: 10.1016/j.jpsychires.2022.01.056. Epub 2022 Feb 2. J Psychiatr Res. 2022. PMID: 35149436
The presentation of psychiatric symptoms in pediatric low-grade brain tumors is challenging because this can delay proper diagnosis and treatment. We performed a systematic review of psychiatric presenting symptoms of low-grade brain tumors in pediatri …
The presentation of psychiatric symptoms in pediatric low-grade brain tumors is challenging because this can delay proper diag …
Liquid Biopsy in Low-Grade Glioma: A Systematic Review and a Proposal for a Clinical Utility Score.
Zanin L, Sachkova A, Panciani PP, Rohde V, Fontanella MM, Schatlo B. Zanin L, et al. Cell Mol Neurobiol. 2023 Nov;43(8):3833-3845. doi: 10.1007/s10571-023-01406-9. Epub 2023 Sep 13. Cell Mol Neurobiol. 2023. PMID: 37704931 Free PMC article. Review.
Liquid biopsy research on Low-Grade gliomas (LGG) has remained less conspicuous than that on other malignant brain tumors. ...Circulating protein-(a) vitronectin discriminates LGG from HGG (Sn:98%, Sp:91%, CUS: 3, LOE: III), (b) CTLA-4 discriminates LGG from HGG, (c …
Liquid biopsy research on Low-Grade gliomas (LGG) has remained less conspicuous than that on other malignant brain tumors. ... …
Patients' Survival with Astrocytoma After Treatment: a Systematic Review and Meta-analysis of Clinical Trial Studies.
Salari N, Fatahian R, Kazeminia M, Hosseinian-Far A, Shohaimi S, Mohammadi M. Salari N, et al. Indian J Surg Oncol. 2022 Jun;13(2):329-342. doi: 10.1007/s13193-022-01533-7. Epub 2022 Apr 25. Indian J Surg Oncol. 2022. PMID: 35782798 Free PMC article. Review.
Considering the importance of patient's outcomes with astrocytoma and lack of general statistics, this study aimed to determine the survival of patients with high-grade astrocytoma and low-grade astrocytoma after treatments. ...The highes …
Considering the importance of patient's outcomes with astrocytoma and lack of general statistics, this study aimed to determine the s …
A systematic review of outcome in intramedullary ependymoma and astrocytoma.
Hamilton KR, Lee SS, Urquhart JC, Jonker BP. Hamilton KR, et al. J Clin Neurosci. 2019 May;63:168-175. doi: 10.1016/j.jocn.2019.02.001. Epub 2019 Mar 2. J Clin Neurosci. 2019. PMID: 30833131

Patients undergoing gross-total resection (GTR) are 5.37 times more likely to survive than patients with lesser volumes of tumor resected (HR for OS 1.68, p < 0.01). High-grade tumors were associated with a 14 times risk of death over low-grade tumors (HR

…
Patients undergoing gross-total resection (GTR) are 5.37 times more likely to survive than patients with lesser volumes of tumor resected (H …
Resolving mystery behind autonomous retrogression of low-grade gliomas: A systematic review.
Ahmed SI, Bareeqa SB, Samar SS, Jilanee SDA. Ahmed SI, et al. J Pak Med Assoc. 2020 Dec;70(12(B)):2441-2448. doi: 10.47391/JPMA.581. J Pak Med Assoc. 2020. PMID: 33475560 Free article.
OBJECTIVE: To review evidence-based data on spontaneous retrogression of low-grade gliomas with respect to interval till regression, type of glioma and patient outcome. ...Literature suggested that low-grade gliomas should undergo serial imaging before …
OBJECTIVE: To review evidence-based data on spontaneous retrogression of low-grade gliomas with respect to interval till regre …
Malignant Progression of Diffuse Low-grade Gliomas: A Systematic Review and Meta-analysis on Incidence and Related Factors.
Nakasu S, Nakasu Y. Nakasu S, et al. Neurol Med Chir (Tokyo). 2022 Apr 15;62(4):177-185. doi: 10.2176/jns-nmc.2021-0313. Epub 2022 Feb 22. Neurol Med Chir (Tokyo). 2022. PMID: 35197400 Free PMC article.
Malignant progression of diffuse low-grade glioma (LGG) is a critical event affecting patient survival; however, the incidence and related factors have been inconsistent in literature. ...
Malignant progression of diffuse low-grade glioma (LGG) is a critical event affecting patient survival; however, the incidence …
Systematic Review of WHO Grade 4 Astrocytoma in the Cerebellopontine Angle: The Impact of Anatomic Corridor on Treatment Options and Outcomes.
Dang DD, Gong AD, Dang JV, Mugge LA, Mansinghani S, Ziu M, Cohen AL, Vyas N. Dang DD, et al. J Neurol Surg Rep. 2023 Oct 16;84(4):e129-e139. doi: 10.1055/a-2172-7770. eCollection 2023 Oct. J Neurol Surg Rep. 2023. PMID: 37854309 Free PMC article.
Background Despite advances in multimodal oncologic therapies and molecular genetics, overall survival (OS) in patients with high-grade astrocytomas remains poor. We present an illustrative case and systematic review of rare, predominantly extra-axial World Health O …
Background Despite advances in multimodal oncologic therapies and molecular genetics, overall survival (OS) in patients with high-grade …
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
Abrigo JM, Fountain DM, Provenzale JM, Law EK, Kwong JS, Hart MG, Tam WWS. Abrigo JM, et al. Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2. Cochrane Database Syst Rev. 2018. PMID: 29357120 Free PMC article. Review.
BACKGROUND: Gliomas are the most common primary brain tumour. They are graded using the WHO classification system, with Grade II-IV astrocytomas, oligodendrogliomas and oligoastrocytomas. Low-grade gliomas (LGGs) are WHO Grade II infiltra …
BACKGROUND: Gliomas are the most common primary brain tumour. They are graded using the WHO classification system, with Grade …
59 results